Firestormm
Senior Member
- Messages
- 5,055
- Location
- Cornwall England
I couldn't see that anyone had posted this before - but do remove or merge if there is an existing thread.
Some of the answers (?) that I picked up on last night from the Facebook discussion. Seemed to leave more questions to be honest (and I think that was the feeling among many posting to be fair) but there we go:
https://www.facebook.com/pages/Whitt...179671?sk=wall
The order and numbering are my own and not as posted by Annette/WPI by the way
I think that was most of them. I kinda got a bit bored/tired wading through it all last night
Some of the answers (?) that I picked up on last night from the Facebook discussion. Seemed to leave more questions to be honest (and I think that was the feeling among many posting to be fair) but there we go:
https://www.facebook.com/pages/Whitt...179671?sk=wall
The order and numbering are my own and not as posted by Annette/WPI by the way
- 'regarding current research projects that Dr. J was working on: WPI research projects are continuing as planned.'
- 'regarding the Lipkin study: We're currently in discussions with Dr. Lipkin and our team of researchers to determine the best way to move forward.'
- 'WPI is committed to completing all sequencing projects. This information is vital to our moving forward.'
- the Vivint funds are still going to their intended purpose, which is to support the research and clinical program at the institute.
- 'Regarding XMRV testing at VIP Dx. All tests offered by VIP Dx laboratory are clinically validated. If you have further questions about the tests please send your questions to info@VIPdx'
- 'There are many questions regarding WPI's research involving patients from the UK. UK patients are a part of WPI's ongoing research program. We remain strongly committed to world wide research on behalf of all patients who suffer from ME and similarly presenting illnesses.'
- 'We have offered Judy access to any necessary materials she needs to answer the concerns of the journal Science. WPI is not in possession of Judy's notebooks.'
- 'Many house bound patients from the UK have asked about being included in WPI's research. While we would like to include all patients who desire to be in this study, our current study is at capacity. We're sorry if Judy offered to include you in studies which are already full. However, we'll make announcements on the WPI website when new studies are open for enrolment.'
- 'The circumstances regarding the cell lines that were sent to Dr. Lombardi have been misrepresented by Judy. These cell lines were ordered for Dr. Lombardi's research and had nothing to do with the institutes's RO1 [NIH Research Grant].'
- 'Many of you have questions regarding the blood working group. The purpose of this phase of the BWG study was to determine if current assays could reproducibly detect XMRV/MLV in blood samples.
"They concluded that these results indicate that current assays do not reproducibly detect XMRV/MLV in blood samples and that blood donor screening is not warranted."
It is important to note that the results reported in the blood working were not based on the testing methods that are used in the clinical laboratory.' - 'As part of the institute's research review process we will be following up on these types of concerns. Those of you with individual questions should write a letter to WPI for further follow up. If you are a UK patient who has already been formally enrolled in a WPI study but your sample has not yet been collected, we will get in touch with you.
WPI address is:
Whittemore Peterson Institute
1664 N Virginia St., MS0552
University of Nevada, Reno
Reno, NV 89557
Please email info@wpinstitute.org your personal information and in the subject line please post UK Study . I'm sorry to hear you are so sick.' - 'Although human gamma retroviral studies have presented many complicated challenges, we feel it is important to continue this line of research for now. Studies such as these involving pathogens, are part of a much more comprehensive research program at the institute. WPI scientists are continuing studies surrounding inflammation, immune dysfunction and other future biomarkers of disease. '
- 'Each person at the Center for Translational Medicine is given an individualized treatment plan. As far as I know there is no magic bullet or one answer that fits all. I do feel that it is uplifting and thus very appropriate to share the stories about successful patient outcomes while also protecting a patients right to their privacy.
Published patient case studies can be a valuable way to provide appropriate information to the public.
It is our greatest hope that all patients can one day be provided with effective treatments. Discovering those answers are at the very core of WPI's reason for being.'
I think that was most of them. I kinda got a bit bored/tired wading through it all last night